Complementary Diagnostics

Clinical Cancer Drug Response Assays

Clinical Assays to Predict Response

KIYATEC is driving the future of clinical complementary diagnostics for cancer patients to provide more accurate predictions of patient-specific response to cancer treatments. ┬áPlacing the patient’s own living cancer cells into a more biologically relevant 3D culture environment, KIYATEC cell-based assays can better assist oncologists with improved response data and faster turnaround!

 

 


x Shield Logo
This Site Is Protected By
The Shield →